929 results on '"Kondoh, Yasuhiro"'
Search Results
2. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy
3. Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)
4. Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database
5. Squamous metaplasia is an indicator of acute exacerbation in patients with usual interstitial pneumonia / idiopathic pulmonary fibrosis
6. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020–2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society
7. Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infection
8. Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR
9. Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
10. Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
11. Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry
12. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
13. Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
14. Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease
15. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study
16. COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases
17. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.
18. Interstitial pneumonia with autoimmune features and histologic usual interstitial pneumonia treated with anti-fibrotic versus immunosuppressive therapy
19. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis
20. Noninvasive Ventilation and High-Flow Oxygen Therapy for ARDS: Does Noninvasive Ventilatory Management Improve the Outcome of ARDS Patients?
21. Home monitoring in interstitial lung diseases
22. MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease
23. Idiopathic Pulmonary Fibrosis Incidentally Detected by CT Scan as Interstitial Lung Abnormalities
24. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
25. End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
26. Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases
27. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis
28. Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis
29. Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study
30. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure
31. The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease
32. Presence of focal usual interstitial pneumonia is a key prognostic factor in progressive pulmonary fibrosis.
33. Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.
34. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
35. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a cohort study
36. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease
37. Pulmonary rehabilitation for idiopathic pleuroparenchymal fibroelastosis: A retrospective study on its efficacy, feasibility, and safety
38. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
39. Challenges in the diagnosis of interstitial lung disease
40. 過去10年間に当院に入院した結核性髄膜炎の臨床的検討
41. Prognostic role of interferon‐lambda 3 in anti‐MDA5–positive dermatomyositis‐associated ILD
42. Presence Of Focal Usual Interstitial Pneumonia Is A Key Prognostic Factor In Progressive Pulmonary Fibrosis
43. Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease
44. Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis
45. Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial
46. What parameters can be used to identify early idiopathic pulmonary fibrosis?
47. A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis
48. Prognostic Role of Interferon‐λ3 in Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis‐Associated Interstitial Lung Disease.
49. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study
50. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.